News

Sanofi said it had expected the decision by April 26. Last week an independent advisory committee in France endorsed the drug for reimbursement by health insurance companies and

<p>The original litigation related to Andrx Corporation which Watson acquired for $1.9 billion in 2006. <br /><br />In 2005, Andrx Corporation filed a patent infringement lawsuit in a

The researchers report that a compound that was frequently used to treat high blood pressure can reverse iron overload in mouse models and has the potential to treat

Previous research had identified that increased levels and actions of the enzyme, AMPK, as a control lever for appetite. Suspecting that antipsychotic drugs might spike AMPK in the

AMDL said its subsidiary’s sales network is uniquely positioned to take advantage of the significant marketing opportunity in China. Docetaxel is an anticancer drug that interferes with the

The agency has determined that the balance of benefits and risks no longer support approval of the drug for these indications. Ketek will remain on the market for

Gail Schulze president of YM BioSciences and CEO of YM BioSciences USA, and John Bennett vice president of Corporate Development at YM BioSciences USA, have left their positions.

“Pharmaceutical companies and regulatory agencies need to bring the cutting-edge benefits of biotech drugs to patients as quickly, safely and at the lowest cost possible,” said CTI's president

The re-focused pharmaceutical development program will concentrate on the FM-TP series of compounds targeting metabolic syndrome and its underlying disease states such as diabetes, the systemic inflammation that